Article Information
History
- April 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hirotaka Iwaki1,2,
- Cornelis Blauwendraat1,
- Hampton L. Leonard1,2,
- Mary B. Makarious1,
- Jonggeol J. Kim1,
- Ganqiang Liu3,4,5,
- Jodi Maple-Grødem6,7,
- Jean-Christophe Corvol8,
- Lasse Pihlstrøm9,
- Marlies van Nimwegen10,
- Luba Smolensky11,
- Ninad Amondikar11,
- Samantha J. Hutten11,
- Mark Frasier11,
- Khanh-Dung H. Nguyen12,
- Jacqueline Rick13,
- Shirley Eberly14,
- Faraz Faghri1,
- Peggy Auinger15,
- Kirsten M. Scott16,
- Ruwani Wijeyekoon16,
- Vivianna M. Van Deerlin17,
- Dena G. Hernandez1,
- J. Raphael Gibbs1,
- Aaron G. Day-Williams18,19,
- Alexis Brice20,21,22,
- Guido Alves6,7,23,
- Alastair J. Noyce24,25,
- Ole-Bjørn Tysnes26,27,
- Jonathan R. Evans28,
- David P. Breen29,30,31,
- Karol Estrada12,
- Claire E. Wegel32,
- Fabrice Danjou20,
- David K. Simon33,34,
- Ole A. Andreassen35,36,
- Bernard Ravina37,38,
- Mathias Toft9,39,
- Peter Heutink40,41,
- Bastiaan R. Bloem10,
- Daniel Weintraub42,43,
- Roger A. Barker44,
- Caroline H. Williams-Gray45,
- Bart P. van de Warrenburg10,
- Jacobus J. Van Hilten46,
- Clemens R. Scherzer3,4,
- Andrew B. Singleton1 and
- Mike A. Nalls1,2,*
- 1Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
- 2Data Tecnica International, Glen Echo, MD, USA
- 3Advanced Center for Parkinson’s Disease Research, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- 4Precision Neurology Program, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
- 5School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China
- 6The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway
- 7Department of Chemistry, Bioscience and Environmental Engineering, University in Stavanger, Stavanger, Norway
- 8Assistance-Publique Hôpitaux de Paris, ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France
- 9Department of Neurology, Oslo University Hospital, Oslo, Norway
- 10Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands
- 11The Michael J. Fox Foundation for Parkinson’s Research, New York, NY, USA
- 12Translational Genome Sciences, Biogen, Cambridge, MA, USA
- 13Department of Neurology University of Pennsylvania, Philadelphia, PA, USA
- 14Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA
- 15Department of Neurology, Center for Health + Technology, University of Rochester, Rochester, NY, USA
- 16Department of Clinical Neurosciences, University of Cambridge, John van Geest Centre for Brain Repair, Cambridge, UK
- 17Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Parelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
- 18Flagship Labs 60 Inc, Cambridge, MA, USA
- 19Statistical Genetics, Biogen, Cambridge, MA, USA
- 20Institut du cerveau et de la moelle épinière ICM, Paris, France
- 21Sorbonne Université SU, Paris, France
- 22INSERM UMR1127, Paris, France
- 23Department of Neurology, Stavanger University Hospital, Stavanger, Norway
- 24Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
- 25Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK
- 26Department of Neurology, Haukeland University Hospital, Bergen, Norway
- 27Department of Clinical Medicine, University of Bergen, Bergen, Norway
- 28Department of Neurology, Nottingham University NHS Trust, Nottingham, UK
- 29Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland
- 30Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, Scotland
- 31Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
- 32Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA
- 33Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA
- 34Harvard Medical School, Boston, MA, USA
- 35NORMENT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Norway
- 36Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway, Norway
- 37Voyager Therapeutics, Cambridge, MA, USA
- 38Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA
- 39Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 40German Center for Neurodegenerative Diseases-Tubingen, Tuebingen, Germany
- 41HIH Tuebingen, Tubingen, Tuebingen, Germany
- 42Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- 43Department of Veterans Affairs, Philadelphia, PA, USA
- 44Department of Clinical Neurosciences and WT-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
- 45Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- 46Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
- ↵*Corresponding author:
Mike A. Nalls Ph.D., Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 35 Convent Drive, Bethesda, MD 20892, USA, +1-202-468-1533, nallsm{at}mail.nih.gov
Posted April 11, 2020.
